![]() |
市場調査レポート
商品コード
1722119
眼科用PACSの世界市場の評価:デリバリーモデル別、タイプ別、エンドユーザー別、地域別、機会、予測(2018年~2032年)Ophthalmology PACS Market Assessment, By Delivery Model, By Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
||||||
カスタマイズ可能
|
眼科用PACSの世界市場の評価:デリバリーモデル別、タイプ別、エンドユーザー別、地域別、機会、予測(2018年~2032年) |
出版日: 2025年05月09日
発行: Market Xcel - Markets and Data
ページ情報: 英文 231 Pages
納期: 3~5営業日
|
世界の眼科用PACSの市場規模は、2024年の1億5,666万米ドルから2032年に2億8,044万米ドルに達すると予測され、予測期間の2025年~2032年にCAGRで7.55%の成長が見込まれます。市場の成長は、遠隔眼科ソリューションの採用の増加、ITの進歩、緑内障、白内障、糖尿病性神経障害、糖尿病性黄斑浮腫などの眼疾患の有病率の増加などによるものと考えられます。National Eye Instituteは、2030年までに430万人の米国人が緑内障に罹患すると推定しています。
眼科疾患の有病率の増加や、視力ケア向上への取り組みの増加、正確な早期発見が可能な方法と手技への要求の高まりは、市場に有利な成長機会をもたらすと予測されます。一方、医療部門でのデジタル技術の利用を強化するための世界各国の政府の活動の増加も、眼科用PACSの需要を増大させています。
眼科用PACSはまた、臨床ワークフローの合理化を支援し、物理的記録への依存を減らすことで、業務効率と診断精度を向上させます。視力障害の増加や熟練した専門家の不足により、効果的な画像管理への要求はここ数年で大幅に高まっています。眼科用PACSのような技術を採用することで、医療従事者は医療過誤を減らすこともできます。
当レポートでは、世界の眼科用PACS市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。
Global ophthalmology PACS market is projected to witness a CAGR of 7.55% during the forecast period 2025-2032, growing from USD 156.66 million in 2024 to USD 280.44 million in 2032. The market's growth can be attributed to the rising adoption of teleophthalmology solutions, advancements in information technology, and increasing prevalence of eye diseases, such as glaucoma, cataracts, diabetic neuropathy, and diabetic macular edema, among others. The National Eye Institute estimates that 4.3 million Americans will have glaucoma by 2030.
The growing prevalence of ophthalmic diseases, along with the increasing efforts to improve vision care and the rising requirement for accurate and early detection methods and procedures, are expected to provide lucrative growth opportunities for the market. Meanwhile, the increasing efforts of governments across the globe to bolster the utilization of digital technologies in the healthcare sector are also augmenting the requirement for ophthalmology PACS.
Ophthalmology PACS also aids in streamlining clinical workflow and reduces the reliance on physical records, thus improving operational efficiency and diagnostic accuracy. The requirement for effective image management has significantly increased over the past few years due to the rising cases of vision impairment and the lack of availability of skilled professionals. By adopting technologies such as ophthalmology PACS, medical professionals are also able to reduce medical errors.
Expansion of the Geriatric Population Boosts Market Demand
The growth of the geriatric population is bolstering the market's demand as the older population is more susceptible to eye diseases and disorders, including glaucoma, diabetic retinopathy, cataracts, and age-related macular degeneration, among others. The World Health Organization (WHO) estimates that 1 in 6 people across the world will be 60 or older by 2030. This demographic shift is augmenting the requirement for advanced data management and ophthalmic imaging solutions, as ongoing monitoring and early detection are critical for treating and managing chronic eye conditions in the older population. Ophthalmology PACS systems aid medical professionals in easily retrieving, sharing, and storing high-resolution eye images, ensuring treatment planning in a time-efficient manner. Thus, medical professionals across the globe are focusing on integrating modern PACS to address the increasing prevalence of age-related eye diseases.
New Product Launches Support Market Expansion
The growing efforts to introduce novel products are driving the growth of the market as they ensure the availability of technologies with advanced data management, imaging, and diagnostic capabilities to meet the evolving requirements of eye care providers. Innovative solutions with cloud-based PACS solutions, high-resolution imaging modalities, and artificial intelligence-powered diagnostic tools allow medical professionals to manage and detect conditions such as macular degeneration, glaucoma, and diabetic retinopathy with improved efficiency and accuracy. Thus, leading companies are focusing on launching new technologies to improve treatment outcomes. For instance, in March 2024, INFINITT Healthcare Co. Ltd. launched its new ophthalmology PACS, which has a state-of-the-art HTML5 viewer that provides a zero-footprint server-side rendered and zero download experience. The technology has been tailored to meet the specific requirements of ophthalmologists. Its worklist management interface streamlines the workflow of medical facilities and categorizes exams, allowing medical professionals to access comprehensive reports and historical data with ease.
Hospitals Account for a Significant Share of the Market
The segment's dominance can be attributed to its large-scale operations, comprehensive imaging requirements, and extensive patient volumes. Large hospitals have the resources and infrastructure to introduce integrated PACS for ensuring the security of data, streamlining complex workflow, and supporting multidisciplinary care teams. Hospitals are also focusing on adopting advanced technologies to improve clinical outcomes and promote digitalization. Their ability to maintain and invest in new digital solutions further allows them to expand their presence in the market.
Additionally, leading hospitals globally are partnering with major medical technology companies to provide digitalized solutions for improving patient diagnosis, providing lucrative growth opportunities for the market. For instance, in January 2023, Manipal Health Enterprises partnered with FUJIFILM India Private Limited to implement a large-scale PACS across its 45 teleradiology facilities and 23 hospitals across India to digitize the management and storage of sensitive medical images and documents and eliminate manual processes.
North America Holds a Major Market Share
The rapid expansion of the market in North America can be attributed to the increasing investments in the healthcare infrastructure in the region, strong presence of key market players, growing awareness about ophthalmic care, and increasing burden of ophthalmic diseases. The Center for Disease Control and Prevention estimates that about 12 million people in the United States who are 40 or older are living with vision impairment.
Additionally, increasing government efforts to promote digitalization of health records, along with the adoption of electronic medical record (EMR) systems, are further supporting the integration of PACS systems across ambulatory surgery centers, hospitals, and specialty clinics. Moreover, growing emphasis on research activities in combination with public health initiatives, including the Vision Health Initiative, is encouraging partnerships between healthcare providers and technology providers.
Meanwhile, the market in the Asia-Pacific is expected to witness significant growth over the forecast period, owing to an increase in investments in healthcare infrastructure and exponential population growth in the region.
Impact of the U.S. Tariff on Global Ophthalmology PACS Market
The tariffs, which are part of a wider trade measure, and expected to affect medical devices manufactured overseas and imported into the United States. The increased financial strain due to the tariffs may force manufacturers to reassess their pricing strategies, resulting in increased costs for healthcare providers and end-users.
Various medical device manufacturers are considering diversifying their supply chains to mitigate the impact of the new tariffs. They are also focusing on shifting their production facilities to countries least affected by tariffs and investing in domestic manufacturing capabilities to reduce dependency on imports.
Moreover, medical professionals relying on imported products to provide ophthalmology care may face a rise in procurement costs, potentially straining budgets, especially in smaller hospitals and clinics, impacting the rate of adoption of advanced imaging technologies. In areas where healthcare funding is limited, access to ophthalmology care may further decline.
Key Players Landscape and Outlook
The key players of the market are focusing on enhancing the overall ecosystem of advanced ophthalmic care, providing lucrative growth opportunities for the market. For instance, in April 2025, Carl Zeiss Meditec AG launched ZEISS DuraVision Gold UV, its latest innovation in lens coating, in India. This innovative product improves lens durability, clarity, and cleanability, improving patient outcomes and satisfaction in eye care. As premium lens technologies like DuraVision Gold UV gain traction, demand for comprehensive ophthalmic diagnostic and treatment solutions-including PACS is expected to rise as PACS systems are integral for managing and storing high-resolution ophthalmic images and patient data efficiently.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.